| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/07/1997 | WO1997028115A1 Antidiabetic agents |
| 08/07/1997 | WO1997027857A1 Antidiabetic agents |
| 08/07/1997 | WO1997027847A1 Method of treating diabetes and related disease states |
| 08/07/1997 | DE19604920A1 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 08/07/1997 | DE19604919A1 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2245529A1 Antidiabetic agents |
| 08/07/1997 | CA2245524A1 Antidiabetic agents |
| 08/07/1997 | CA2244831A1 Method of treating diabetes and related disease states |
| 08/07/1997 | CA2243191A1 Diagnostic method and apparatus |
| 08/06/1997 | EP0787800A2 Plasmid and plasmid vector from Lactobacillus helveticus |
| 08/06/1997 | EP0787739A1 Anti-adhesive piperidine and pyrollidine -carboxylic acids |
| 08/06/1997 | EP0787723A1 Cyclopropachromenecarboxylate derivatives |
| 08/06/1997 | EP0787717A1 Substituted diaryl dicarboxylic acid diguanidines, process for their preparation, their use as inhibitors of the Na+/H+ exchange as well as medicament or diagnostic agent containing them |
| 08/06/1997 | EP0787492A1 Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
| 08/06/1997 | EP0787489A2 Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787127A1 5-lipoxygenase inhibitors |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0787010A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 08/06/1997 | EP0787001A1 Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis |
| 08/06/1997 | EP0787000A1 Quinazolinone pharmaceuticals and use thereof |
| 08/06/1997 | EP0786991A1 Polyamine compounds for treating vascular proliferative disorders |
| 08/06/1997 | EP0786988A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs |
| 08/06/1997 | EP0677107B1 Clotting inhibitor made from protostomia saliva |
| 08/06/1997 | CN1156449A Dihygropyridine derivatives as bradykinin antagonists |
| 08/06/1997 | CN1156447A 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/06/1997 | CN1156047A Chinese-medicinal oral liquor for curing coronary heart disease and angina pectoris and preparing method |
| 08/05/1997 | US5654445 Intermediates for renin inhibitors, hypotensive agents |
| 08/05/1997 | US5654436 Inhibitors of smooth muscle cell proliferation |
| 08/05/1997 | US5654326 1H-indole-3-glyoxylamide SPLA2 inhibitors |
| 08/05/1997 | US5654323 2-nitrogen-containing functional group-halobenzothiazoles; analgesics; antiinflammatory and hypotensive agents; inhibitors of cytokines (including tumor necrosis factor) and phospholipase; septic shock |
| 08/05/1997 | US5654315 Quinuclidine compounds useful in treating diseases |
| 08/05/1997 | US5654310 Antiischemic agents |
| 08/05/1997 | US5654309 Kidney, cardiovascular and respiratory system disorders |
| 08/05/1997 | US5654308 Prevent or treat disease due to insufficient choline function |
| 08/05/1997 | US5654303 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 08/05/1997 | US5654298 Amine derivatives |
| 08/05/1997 | US5654297 Tricyclic thieno-azepine vasopressin antagonists |
| 08/05/1997 | US5654290 Anticoagulant; antitumor agents; absorption by brain tissue |
| 08/05/1997 | US5654279 Tissue destruction in cryosurgery by use of thermal hysteresis |
| 08/05/1997 | US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides |
| 08/05/1997 | CA1339210C Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| 07/31/1997 | WO1997027297A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027183A1 Guanidine derivatives |
| 07/31/1997 | WO1997027177A2 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 07/31/1997 | WO1997026912A2 Anti-cd18 antibodies for use against stroke |
| 07/31/1997 | WO1997026894A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 07/31/1997 | WO1997026890A1 Medicaments containing aromatic azo compounds |
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/31/1997 | DE19602989A1 Arzneimittel, enthaltend aromatische Azoverbindungen A medicament containing aromatic azo compounds |
| 07/31/1997 | DE19602757A1 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung Fixed instant release dosage forms and methods for their preparation |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2243964A1 Solid instant-release forms of administration and processes for their production |
| 07/31/1997 | CA2243958A1 Medicaments containing aromatic azo compounds |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2196388A1 Substituted diaryldicarboxylic acid diguanidides, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 07/30/1997 | EP0786522A2 Enzymatic RNA molecules for treatment of stenotic conditions |
| 07/30/1997 | EP0786467A1 Multiple-fucosylated dicarboxylic acids having anti-adhesive properties |
| 07/30/1997 | EP0786457A1 Azole derivative |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0785926A1 New carboxylic acid derivatives, their preparation and their use |
| 07/30/1997 | EP0785799A1 Process for production of inhibited forms of activated blood factors |
| 07/30/1997 | EP0785770A1 Hemorrhoidal compositions and method of use |
| 07/30/1997 | EP0636146B1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 07/30/1997 | CN1155886A Salts of an anti-migraine indole derivative |
| 07/30/1997 | CN1155838A Indolinone compounds for the treatment of disease |
| 07/30/1997 | CN1155545A Substituted benzodihydropyranyl sulfonylurea, its preparation, use in medicines and the medicines containing the same |
| 07/30/1997 | CN1155538A Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 07/30/1997 | CN1155423A Pingyasan for hypertension |
| 07/29/1997 | US5652368 1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes |
| 07/29/1997 | US5652355 Hybrid oligonucleotide phosphorothioates |
| 07/29/1997 | US5652268 Treating cardiovascular disorders |
| 07/29/1997 | US5652262 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/29/1997 | US5652252 Potassium channel activators |
| 07/29/1997 | US5652251 6-amino-1,4-dihydropyridine compounds as medicaments for treatment of the central nervous system, and processes for their preparation |
| 07/29/1997 | US5652245 Heterocyclic amines having central nervous system activity |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652239 Treatment of strokes, ischemic attack, antagonists of excitatory amino acids glutamate and aspartate |
| 07/29/1997 | CA1339105C Modified proteins |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026265A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026258A1 Angiogenesis inhibiting pyridazinamines |
| 07/24/1997 | WO1997026253A1 Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines |
| 07/24/1997 | WO1997026250A1 Integrin receptor antagonists |
| 07/24/1997 | WO1997026247A1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 07/24/1997 | WO1997025986A1 Intimal thickening inhibitors |
| 07/24/1997 | CA2243446A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | CA2242877A1 Integrin receptor antagonists |
| 07/24/1997 | CA2242775A1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 07/24/1997 | CA2241567A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | CA2240075A1 Novel benzoylguanidine derivatives, process for their preparation and their use in the preparation of medicines |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0784980A1 Collagen hydrolysis accelerator |